GlassScriptPhysician profile
Manuel J Martin
NPI 1710981402
$12,913.70
in general payments reported to CMS, 2019-2025
56 companies · $2,566 in 2025
The $2,566 reported for 2025 was more than what 97% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,637 · 2020: $1,193 · 2021: $1,426 · 2022: $1,353 · 2023: $2,375 · 2024: $2,365 · 2025: $2,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,265 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,264.68 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,557.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,294.87 | 2019-2025 | |
| Glaxosmithkline, LLC. | $1,108.84 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $990.92 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $980.48 | 2019-2025 | Mounjaro, Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $944.54 | 2022-2025 | |
| Gilead Sciences, INC. | $719.33 | 2019-2025 | Descovy |
| Pfizer INC. | $509.95 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $491.61 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $440.09 | 2019-2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $290.72 | 2022-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $227.10 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Paratek Pharmaceuticals, INC. | $227.03 | 2024-2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $226.40 | 2019-2025 | Spravato |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $212.42 | 2025 | Caplyta |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $165.09 | 2019-2025 | Xifaxan |
| Astellas Pharma US INC | $156.33 | 2019-2025 | Veozah |
| Amgen INC. | $152.68 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbott Laboratories | $149.68 | 2019-2024 | Freestyle Libre 3, Proclaim |
| Merck Sharp & Dohme LLC | $138.71 | 2021-2025 | Pifeltro, Capvaxive, Delstrigo |
| Phathom Pharmaceuticals, INC. | $138.17 | 2024-2025 | Voquezna |
| Idorsia Pharmaceuticals US INC | $121.72 | 2023-2024 | Quviviq |
| Shield Therapeutics INC | $118.10 | 2022-2024 | Accrufer |
| Takeda Pharmaceuticals U.S.A., INC. | $115.74 | 2019-2025 | Trintellix |
| Exact Sciences Corporation | $115.49 | 2023-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $103.40 | 2021-2024 | Minimed 780g, Minimed 770g |
| Horizon Therapeutics Plc | $99.91 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $93.99 | 2020-2021 | |
| Amarin Pharma, INC. | $79.13 | 2019-2020 | |
| Allergan, INC. | $77.97 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $74.52 | 2022-2024 | Qelbree, Qelbree |
| Dexcom, INC. | $70.93 | 2024 | Dexcom G6 Transmitter |
| Radius Health, INC. | $68.31 | 2023-2025 | Tymlos |
| Arbor Pharmaceuticals, INC. | $61.84 | 2019-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $57.44 | 2022 | |
| Novartis Pharmaceuticals Corporation | $52.59 | 2021-2023 | |
| Ibsa Pharma INC. | $43.84 | 2020-2021 | |
| Genentech USA, INC. | $38.84 | 2019-2020 | |
| Tms Neurohealth Centers INC. | $32.57 | 2025 | Tms Neurohealth Centers INC. |
| Viiv Healthcare Company | $31.16 | 2024 | Apretude |
| Alvogen INC | $30.35 | 2023-2024 | Teriparatide |
| Amneal Pharmaceuticals LLC | $27.94 | 2020-2021 | |
| Alk-Abello, INC | $27.63 | 2024 | Grastek, Ragwitek, Odactra |
| Indivior INC. | $26.49 | 2025 | Sublocade |
| Corcept Therapeutics | $24.14 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $23.88 | 2024 | Inspire |
| Axsome Therapeutics, INC. | $23.36 | 2025 | Auvelity |
| Tactile Systems Technology INC | $22.50 | 2019 | |
| Hologic Sales and Service, LLC | $20.54 | 2024 | Aptima |
| Aytu Biopharma, INC. | $19.49 | 2019 | |
| Lundbeck LLC | $17.86 | 2024 | Rexulti |
| Jazz Pharmaceuticals INC. | $16.89 | 2021 | |
| Axonics, INC. | $16.09 | 2021 | |
| Tolmar, INC. | $13.91 | 2024 | |
| Hikma Pharmaceuticals USA | $12.99 | 2023 | Mitigare, Ryaltris |
| Dynavax Technologies Corporation | $9.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manuel Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.